Jim Simons
EPIX

Jim Simons’s ESSA Pharma EPIX Stock Holding History

Jim Simons’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,234
Closed -$160K – 3793
2023
Q4 		$160K Buy
+24,234
New +$119K ﹤0.01% 3198
2023
Q1 		– Sell
-34,624
Closed -$87K – 4072
2022
Q4 		$87K Sell
34,624
-151,286
-81% -$434K ﹤0.01% 3660
2022
Q3 		$338K Buy
185,910
+160,310
+626% +$422K ﹤0.01% 3154
2022
Q2 		$81K Buy
+25,600
New +$143K ﹤0.01% 3898
2021
Q4 		– Sell
-141,500
Closed -$1.13M – 3976
2021
Q3 		$1.13M Buy
141,500
+121,800
+618% +$1.94M ﹤0.01% 2482
2021
Q2 		$563K Sell
19,700
-55,800
-74% -$1.62M ﹤0.01% 2920
2021
Q1 		$2.19M Buy
75,500
+12,697
+20% +$295K ﹤0.01% 2167
2020
Q4 		$749K Sell
62,803
-28,997
-32% -$204K ﹤0.01% 2640
2020
Q3 		$633K Buy
91,800
+54,023
+143% +$367K ﹤0.01% 2737
2020
Q2 		$234K Buy
+37,777
New +$179K ﹤0.01% 3119
2020
Q1 		– Sell
-12,813
Closed -$70K – 3524
2019
Q4 		$70K Buy
+12,813
New +$59.6K ﹤0.01% 3359

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Jim Simons's EPIX Position: Q1 2024 in Review

Jim Simons sold out of ESSA Pharma (EPIX) in Q1 2024, closing a stake of 24,234 shares — an estimated $160K sold.

Jim Simons first reported a position in EPIX in Q4 2019 and held it in 11 quarters. The position peaked at $2.19M in Q1 2021. 33 funds tracked by Wall St. Rank hold EPIX as of Q1 2024.

  • Jim Simons reported no remaining ESSA Pharma position as of Q1 2024 after selling out during the quarter.
  • Jim Simons sold 24,234 ESSA Pharma shares in Q1 2024, an estimated $160K.
  • Jim Simons first reported a position in ESSA Pharma in Q4 2019 and held it in 11 quarters.
  • Jim Simons's ESSA Pharma position peaked at $2.19M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.